Publication date: 3rd October 2022
In this case study module, Sung-Bae Kim discusses key risk factors for disease recurrence in HR+/HER2- early breast cancer and outlines the prognostic tools that can be used for to help predict the risk for this, with reference to the disease course of a 34-year old HR+/HER2- early breast cancer patient.
After completing this activity, you will be able to:
- Describe the prognostic variables which can influence recurrence risk in HR+HER2- early breast cancer
- Explain the methods that can help determine prognosis and treatment efficacy
Expiration date: 3rd October 2023
Estimated time to complete: 15 minutes
When you have completed this activity you will be asked to fill in a short evaluation survey. Your feedback helps us to give you the best learning experience.
Sign up for new content alerts
Enter your email address below and we'll contact you as soon as new content is launched!